Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease
- 13 May 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 363 (3) , 243-246
- https://doi.org/10.1016/j.neulet.2004.03.072
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Manganese Exposure on MPTP NeurotoxicitiesNeuroToxicology, 2003
- Antiapoptotic role of NF‐κB in the auto‐oxidized dopamine‐induced apoptosis of PC12 cellsJournal of Neurochemistry, 2001
- Hypothesis: Can N-acetylcysteine be beneficial in Parkinson's disease?Life Sciences, 1999
- Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patientsNeurology, 1996
- Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.Journal of Clinical Investigation, 1995
- Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons — A possible novel pathogenetic mechanism in Parkinson's diseaseNeuroscience Letters, 1994
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Administration of l-2-oxothiazolidine-4-carboxylate increases glutathione levels in rat brainBrain Research, 1989
- Prevention of progression of Parkinson's disease with antioxidative therapyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
- Effect of 1-methyl-4-phemyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouseNeuropharmacology, 1986